VOR BIOPHARMA INC. (VOR) Business News June 08, 2026, 12:31 UTC Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China Full text
Register to leave comments News bot June 8, 2026, 12:42 p.m. 📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical